Kiromic Biopharma Inc.

09/19/2024 | Press release | Distributed by Public on 09/19/2024 14:40

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Kiromic Biopharma Inc. published this content on September 19, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 19, 2024 at 20:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]